PhD Program in Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Reggio Emilia, Italy; Department of Surgery, Otolaryngology Unit, Azienda USL-IRCCS di Reggio Emilia, viale Risorgimento 80, 42123 Reggio Emilia, Italy.
Department of Surgery, Otolaryngology Unit, Azienda USL-IRCCS di Reggio Emilia, viale Risorgimento 80, 42123 Reggio Emilia, Italy.
Auris Nasus Larynx. 2021 Jun;48(3):511-517. doi: 10.1016/j.anl.2020.10.014. Epub 2020 Oct 28.
Patients with acute respiratory failure due to COVID-19 have a high likelihood of needing prolonged intubation and may subsequently require tracheotomy. Usually, the choice of technique (percutaneous dilatational tracheotomy [PDT] versus open surgical tracheotomy [OST]) depends on the preference of surgeons and patient-related factors. In case of COVID-19, airborne spread of viral particles and limited time of apnea must be considered in the choice of the safest technique. The aim of this study is to compare the complication rates and offer an assessment of relative risks and benefits of PDT versus OST in patients with severe COVID-19.
We performed a retrospective study considering 47 consecutive patients affected by severe acute respiratory distress syndrome due to SARS-CoV-2 infection, needing invasive mechanical ventilation and subsequent tracheostomy. This study was performed at the Intensive Care Unit of our tertiary referral center. Complication rates were analyzed.
Seventeen patients underwent PDT and 30 patients were submitted to OST. Twenty-six patients (55.3%) had post-operative complications (local infection, hemorrhage, subcutaneous emphysema) with no significant difference between PDT and OST.
PDT and OST are characterized by similar postoperative complication rates in severe COVID-19 patients. These findings suggest that OST might be preferred if expert ENT surgeons are available, as PDT could result in longer apnea and exposure to generated aerosol. However, authors recommend considering either OST or PDT at the discretion of the medical staff involved, according to the personal experience of the operators performing the procedure.
因 COVID-19 导致急性呼吸衰竭的患者极有可能需要长时间插管,并随后需要进行气管切开术。通常,技术选择(经皮扩张气管切开术 [PDT] 与开放式外科气管切开术 [OST])取决于外科医生的偏好和患者相关因素。在 COVID-19 的情况下,在选择最安全的技术时,必须考虑病毒颗粒的空气传播和有限的呼吸暂停时间。本研究的目的是比较 PDT 与 OST 在重症 COVID-19 患者中的并发症发生率,并评估相对风险和获益。
我们进行了一项回顾性研究,纳入了 47 例因 SARS-CoV-2 感染导致严重急性呼吸窘迫综合征、需要有创机械通气和随后进行气管切开术的连续患者。本研究在我们的三级转诊中心的重症监护病房进行。分析了并发症发生率。
17 例患者接受 PDT,30 例患者接受 OST。26 例患者(55.3%)出现术后并发症(局部感染、出血、皮下气肿),PDT 与 OST 之间无显著差异。
在重症 COVID-19 患者中,PDT 和 OST 的术后并发症发生率相似。这些发现表明,如果有耳鼻喉科专家外科医生可用,OST 可能更受欢迎,因为 PDT 可能导致更长的呼吸暂停和暴露于产生的气溶胶。然而,作者建议根据操作人员的个人经验,由参与的医务人员自行决定选择 OST 或 PDT。